Enveric Biosciences, Inc.
ENVB
$1.46
$0.042.47%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -3.03M | -1.63M | -2.19M | -1.87M | -2.52M |
| Total Depreciation and Amortization | 36.80K | 37.20K | 39.50K | 40.40K | 40.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 125.10K | 108.30K | 269.70K | 58.30K | 206.30K |
| Change in Net Operating Assets | 421.30K | -768.90K | 100.10K | -300.00K | 382.80K |
| Cash from Operations | -2.44M | -2.26M | -1.78M | -2.08M | -1.89M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 5.86M | 2.50M | 2.69M | 2.99M | 449.10K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -18.80K | -- | -- | -- | -- |
| Cash from Financing | 5.85M | 2.50M | 2.69M | 2.99M | 449.10K |
| Foreign Exchange rate Adjustments | -12.90K | -15.10K | 15.60K | -9.60K | -3.60K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 3.39M | 231.30K | 919.90K | 907.80K | -1.44M |